EdgarLookup

Immix Biopharma, Inc. — SC 13G Filings

3 SC 13G filings on record

This page lists all SC 13G filings submitted to the SEC by Immix Biopharma, Inc. (IMMX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Immix Biopharma, Inc. has filed 3 SC 13G documents with the SEC since 2021. To view all SEC filings by Immix Biopharma, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 3 4 4/A 424B4 424B5 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DRS DRSLTR EFFECT FWP RW RW WD S-1 S-1/A S-3 S-8 SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13G — 0001493152-24-005212 Feb 7, 2024 —
SC 13G — 0001493152-22-003631 Feb 9, 2022 —
SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-21-012282 Dec 28, 2021 —